← back to search

Silvia Bertagnolio

World Health Organization · ID
Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV Research and Treatment, and HIV-related health complications and treatments.
h-index
48
citations
8,090
works
155
NIH funding
primary concept
Medicine
email

Recent publications

High risk of COVID-19 mortality in people living with advanced HIV disease in South Africa: A retrospective cohort study.
2026cited by 0position: contributordoi
Antimicrobial resistance in bacterial pathogens causing community-acquired and hospital-acquired lower respiratory tract infections (2010–24): a systematic review and meta-analysis
The Lancet Microbe 2026cited by 0position: contributordoi
Long COVID Syndrome, Mortality and Morbidity in Patients Hospitalized with COVID-19 From 16 Countries: The World Heart Federation Global COVID-19 Study
Global Heart 2025cited by 6position: middledoi
Long COVID Syndrome, Mortality and Morbidity in Patients Hospitalized with COVID-19 From 16 Countries: The World Heart Federation Global COVID-19 Study.
2025cited by 2position: contributordoi
In-hospital mortality among children and adults hospitalized with COVID-19 in Africa across pre-delta, delta, and omicron SARS-CoV-2 waves.
2025cited by 0position: contributordoi
The scope of the antimicrobial resistance challenge.
2024cited by 210position: contributordoi
WHO global research priorities for antimicrobial resistance in human health
The Lancet Microbe 2024cited by 177position: firstdoi
WHO global research priorities for antimicrobial resistance in human health.
2024cited by 117position: contributordoi
A reference standard for urinary tract infection research: a multidisciplinary Delphi consensus study.
2024cited by 50position: contributordoi
Validation of prognostic models predicting mortality or ICU admission in patients with COVID-19 in low- and middle-income countries: a global individual participant data meta-analysis.
2024cited by 2position: contributordoi
Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19.
2024cited by 2position: contributordoi
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis
The Lancet Microbe 2023cited by 164position: lastdoi
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis.
2023cited by 163position: contributordoi
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis.
2023cited by 118position: contributordoi
Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action.
2023cited by 55position: contributordoi
Global knowledge gaps on antimicrobial resistance in the human health sector: A scoping review
International Journal of Infectious Diseases 2023cited by 25position: lastdoi
Antimicrobial resistance: Strengthening surveillance for public health action.
2023cited by 19position: contributordoi
Global associations of key populations with HIV-1 recombinants: a systematic review, global survey, and individual participant data meta-analysis.
2023cited by 14position: contributordoi
Global knowledge gaps on antimicrobial resistance in the human health sector: A scoping review.
2023cited by 13position: contributordoi
Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries.
2023cited by 8position: contributordoi
Associated factors for mortality in a COVID-19 colombian cohort: is the third wave relevant when Mu variant was predominant epidemiologically?
2023cited by 1position: contributordoi
Real-life implications of prevalence meta-analyses? Doi plots and prediction intervals are the answer - Authors' reply.
2023cited by 0position: contributordoi
Associated Factors for Mortality in a COVID-19 Colombian Cohort by Epidemic Wave: Is the Predominance of Mu Variant Relevant?
2023cited by 0position: contributordoi
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19.
2022cited by 143position: contributordoi
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
2022cited by 11position: contributordoi
Epidemiology of HIV drug resistance in low- and middle-income countries and WHO global strategy to monitor its emergence.
2022cited by 9position: contributordoi
The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018.
2022cited by 9position: contributordoi
Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping review.
2022cited by 5position: contributordoi
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.
2022cited by 5position: contributordoi
The First 110,593 COVID-19 Patients Hospitalised in Lombardy: A Regionwide Analysis of Case Characteristics, Risk Factors and Clinical Outcomes.
2022cited by 4position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Raph L Hamers · Surin Hospital10 papers (2019–2026)Andrew Phillips · Wake Forest University8 papers (2012–2020)Michael R. Jordan · Tufts University7 papers (2012–2017)Jens Lundgren · Aalborg University5 papers (2012–2020) · 5 papers (2021–2026)Valentina Cambiano · University College London5 papers (2012–2020)Ravindra K. Gupta · University of Cambridge5 papers (2012–2020)Morgane Rolland · Makerere University Walter Reed Project4 papers (2019–2023)Waasila Jassat · National Health Laboratory Service4 papers (2021–2026)Andrea De Luca · Università Campus Bio-Medico4 papers (2012–2018) · 3 papers (2012–2024)Deenan Pillay · University of the Western Cape3 papers (2012–2014) · 3 papers (2012–2014)Alessandro Cassini · Service de la Santé Publique3 papers (2023–2024)Deenan Pillay · University of Oxford3 papers (2017–2020)Fumiyo Nakagawa · UCLA Health3 papers (2014–2018) · 3 papers (2012–2020)John W. Mellors · University of Pittsburgh3 papers (2017–2020)Anton Pozniak · London School of Hygiene & Tropical Medicine3 papers (2017–2020)Daniel R. Kuritzkes · Brigham and Women's Hospital3 papers (2017–2020)